Clinical Trial Update: A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating how Novo Nordisk's investigational compound NNC0487-0111 works in adults with obesity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: COMPLETED